SCHEMBL1965650

SCHEMBL1965650

N#Cc1cc(C(N)=O)ccc1-n1c(Nc2c(Cl)cccc2Cl)nc2cc(C(=O)O)ccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 2/20 0.43
RORC P51449 4/20 0.39
CSNK2A2 P19784 2/20 0.39
CSNK2B P67870 2/20 0.39
CSNK2A1 P68400 2/20 0.39
HSD17B10 Q99714 1/20 0.38
PIK3CD O00329 1/20 0.36
PIK3CA P42336 1/20 0.36
PIK3CB P42338 1/20 0.36
MTOR P42345 1/20 0.36
PIK3CG P48736 1/20 0.36
THRB P10828 1/20 0.36
JAK2 O60674 2/20 0.36
JAK1 P23458 2/20 0.36
TYK2 P29597 2/20 0.36
JAK3 P52333 2/20 0.36
IDH1 O75874 1/20 0.35
EGFR P00533 1/20 0.35
ERBB2 P04626 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1964624 0.86 LCK (0.45) LCKRORCCSNK2A2CSNK2BCSNK2A1
SCHEMBL1967011 0.86 LCK (0.45) LCKRORCCSNK2A2CSNK2BCSNK2A1
SCHEMBL1967758 0.83 LCK (0.45) LCKRORCCSNK2A2CSNK2BCSNK2A1
SCHEMBL1967636 0.81 LCK (0.46) LCKRORCCSNK2A2CSNK2BCSNK2A1
SCHEMBL1966409 0.81 LCK (0.42) LCKRORCCSNK2A2CSNK2BCSNK2A1
SCHEMBL1973510 0.80 HSD17B10 (0.44) LCKRORCCSNK2A2CSNK2BCSNK2A1
SCHEMBL1964840 0.79 LCK (0.47) LCKRORCCSNK2A2CSNK2BCSNK2A1
SCHEMBL1965823 0.77 LCK (0.42) LCKRORCCSNK2A2CSNK2BCSNK2A1
SCHEMBL1965510 0.77 HSD17B10 (0.42) LCKRORCCSNK2A2CSNK2BCSNK2A1
SCHEMBL1967031 0.77 LCK (0.42) LCKRORCCSNK2A2CSNK2BCSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2334652-A1 1H-BENZ IMIDAZOLE-5-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS Boehringer Ingelheim International GmbH (DE) 2011-06-22 EP claimed